Skip to main content
Adocia logo

Adocia — Investor Relations & Filings

Ticker · ADOC ISIN · FR0011184241 LEI · 969500ZL79KYH9PTYP78 PA Real estate activities
Open in API
Filings indexed 828 across all filing types
Latest filing 2024-03-15 Regulatory Filings
Country FR France
Listing PA ADOC

About Adocia

https://www.adocia.com

Adocia is a clinical-stage biotechnology company that specializes in developing innovative treatments for metabolic diseases, with a primary focus on diabetes and obesity. The company's core expertise is the development of novel formulations of approved peptides, proteins, and metabolic hormones, such as insulin, to improve their therapeutic efficacy. Adocia leverages proprietary technology platforms to create a pipeline of specialty products. Its research also extends to novel cell therapy approaches, including an immunoprotective scaffold for cell delivery. The company's business model involves advancing its product candidates to clinical proof-of-concept before licensing them to partners for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document explicitly states its purpose: to release the 'Total number of outstanding shares as well as its voting rights as of February 29th, 2024,' citing compliance with French 'Code de Commerce' and AMF regulations (Article L. 233-8 II and Article 223-16). This type of mandatory disclosure, detailing the total number of shares and voting rights, is a specific regulatory filing requirement in France, often related to major shareholding changes or capital structure updates. It is not a full financial report (10-K or IR), an earnings release (ER), or a management discussion (MDA). It most closely aligns with notifications regarding changes in share ownership or capital structure. Among the provided codes, 'Major Shareholding Notification' (MRQ) is the closest fit for reporting changes in the total share count that underpins ownership thresholds, although this specific filing is often categorized under general regulatory announcements. Given the content focuses purely on the share count and voting rights as mandated by the AMF, it fits the criteria for a specific regulatory disclosure. Since there isn't a perfect code for 'Total Shares Outstanding Disclosure,' and it is a formal regulatory announcement, it falls under the general regulatory category or a share/capital change notification. Because it is a formal, periodic disclosure of the total share base used for calculating ownership thresholds, it is best classified as a Major Shareholding Notification (MRQ) or, if that is too specific, a Regulatory Filing (RNS). Given the focus on the total share count which is the basis for threshold calculations, MRQ is a strong candidate, but since it's a general disclosure of the total base rather than a notification *of* a threshold crossing, RNS (Regulatory Filings) serves as the most accurate general regulatory bucket for this specific French disclosure type when a more precise code isn't available. However, looking closely at the definitions, MRQ is for 'Notification of changes in significant share ownership levels (crossing thresholds)'. This document reports the total base, which is a prerequisite for threshold crossing. Since it is a mandatory, periodic regulatory disclosure, RNS is the safest fallback. Let's re-evaluate: This is a mandatory disclosure of the total share base, which is a key input for major shareholding notifications. In many jurisdictions, this specific disclosure is treated as a general regulatory filing. I will classify it as RNS as it is a formal regulatory announcement that doesn't fit the other specific financial report types.
2024-03-15 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is a press release titled "ADOCIA annonce sa participation à des évènements clés" (ADOCIA announces its participation in key events). It lists several upcoming conferences and investor meetings (Roth Conference, Bio-Europe Spring, etc.) where the management team will be present. This type of announcement, informing investors about management's schedule for meetings and presentations, is characteristic of investor relations activities. It is not a formal regulatory report (like 10-K or IR), nor is it a transcript or a dividend notice. It fits best under the general category of investor communication related to corporate activities, which aligns most closely with Investor Presentation (IP) if it were a presentation, or more generally, a communication aimed at investors. Since the content is purely an announcement about future participation in investor-focused events, it is best classified as an Investor Presentation (IP) proxy, or if we strictly follow the definitions, it is an announcement about future engagement, which often accompanies or precedes an Investor Presentation or is a standalone IR communication. Given the options, and that it details events where management will present company information to investors, 'Investor Presentation' (IP) is the closest fit for this type of forward-looking investor engagement announcement, although 'RPA' (Report Publication Announcement) could also be considered if it were announcing the release of a formal report. Since it announces participation in investor conferences, IP is more appropriate than RPA or RNS.
2024-03-06 French
Inside Information / Other news releases
Report Publication Announcement Classification · 1% confidence The document is titled "ADOCIA Announces Its Participation at Key Events" and lists several upcoming conferences and investor meetings where the management team is scheduled to participate (e.g., Roth Conference, Bio-Europe Spring, Equity Forum Spring). This type of announcement, detailing future investor engagement activities, is a standard form of communication to the market regarding investor relations activities. It is not a formal financial report (like 10-K or IR), a transcript (CT), or a specific regulatory filing like a Director's Dealing (DIRS) or Dividend Notice (DIV). It fits best under the general category of investor-focused communication that doesn't fit a more specific financial or corporate action code. Given the options, this is a general announcement related to investor outreach, which often falls under Regulatory Filings (RNS) if it doesn't fit elsewhere, or potentially Investor Presentation (IP) if it were the presentation itself, but here it is an announcement *about* attending events. Since it is a press release announcing future participation in investor events, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback, although it is highly specific to investor relations activities.
2024-03-06 English
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 1% confidence The document is titled "ADOCIA publie ses résultats financiers du 4 ème trimestre 2023 et fait le point sur ses activités" (ADOCIA publishes its financial results for the 4th quarter of 2023 and provides an update on its activities). It contains detailed financial figures for Q4 2023 and the full year 2023, including revenue tables, cash position analysis, and debt details. It also includes management commentary on financial performance and operational updates (M1Pram, AdoShell, BC Combo). This structure—presenting period-specific financial results, commentary, and key operational milestones—is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since it provides detailed financial tables and management discussion, it goes beyond a simple 'Earnings Release' (ER) which is usually just the highlights. It covers a period shorter than a year (Q4 2023), making it a comprehensive quarterly report. However, the text explicitly states: "Les résultats financiers audités de l'année 2023 seront publiés en avril 2024." This suggests the Q4/FY2023 figures presented here are likely unaudited highlights released ahead of the full Annual Report (10-K) or a more formal statutory filing. Given the focus on quarterly financial performance and operational updates, the most appropriate classification is Interim / Quarterly Report (IR). It is not a Call Transcript (CT) as it is a press release, nor is it a full Annual Report (10-K) which covers the full fiscal year with audited statements (which are explicitly stated to come later). Q4 2023
2024-02-27 French
Inside Information / News release on accounts, results
Earnings Release Classification · 1% confidence The document is titled "ADOCIA Reports Fourth Quarter 2023 Financial Results and Provides a Business Update." It contains detailed financial tables for the fourth quarter and full year 2023, discusses cash position, debt, revenue breakdown, and provides operational updates on key drug candidates (M1Pram, AdoShell® Islets, BC Combo). The text explicitly states, "Full year audited financial results for 2023 will be published in April 2024," indicating this document is a preliminary release of quarterly results, not the full annual report (10-K) or the final audited report. This structure—key financial highlights, management commentary, and operational updates released periodically—is characteristic of an Earnings Release (ER). It is not a transcript (CT), a presentation (IP), or a general regulatory filing (RNS), as it focuses specifically on the period's financial performance. Q4 2023
2024-02-27 English
Inside Information / Other news releases
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release dated February 13th, 2024, announcing the 'Total number of outstanding shares as well as its voting rights as of January 31st, 2024.' It explicitly references compliance with French regulatory articles (L. 233-8 II of the French « Code de Commerce » and article 223-16 of the AMF charter). This type of filing, which reports changes in the total number of shares and voting rights, directly corresponds to the definition of Major Shareholding Notification (MRQ) or, more broadly, a regulatory filing concerning share capital structure changes. Since the core content is the official count of shares and voting rights, which is often required when crossing ownership thresholds or for regulatory transparency, MRQ is the most specific fit. It is not a full report (10-K, IR), an earnings release (ER), or a dividend notice (DIV). It is a specific regulatory disclosure about share count.
2024-02-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.